Intellectus Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Hold
2,301
0.15% 152
2026
Q1
$674K Hold
2,301
0.14% 170
2025
Q4
$807K Sell
2,301
-450
-16% -$152K 0.16% 156
2025
Q3
$889K Sell
2,751
-910
-25% -$283K 0.17% 144
2025
Q2
$1.42M Sell
3,661
-199
-5% -$80K 0.31% 92
2025
Q1
$1.68M Sell
3,860
-150
-4% -$60.2K 0.41% 70
2024
Q4
$1.48M Sell
4,010
-10
-0.2% -$4.18K 0.33% 81
2024
Q3
$2.09M Sell
4,020
-160
-4% -$85.5K 0.53% 49
2024
Q2
$2.27M Sell
4,180
-386
-8% -$204K 0.62% 39
2024
Q1
$2.37M Buy
4,566
+126
+3% +$62.7K 0.62% 43
2023
Q4
$2.09M Buy
4,440
+1,171
+36% +$541K 0.6% 45
2023
Q3
$1.42M Buy
3,269
+486
+17% +$220K 0.45% 59
2023
Q2
$1.24M Sell
2,783
-25
-0.9% -$11.5K 0.37% 72
2023
Q1
$1.29M Buy
2,808
+2
+0.1% +$952 0.41% 68
2022
Q4
$1.44M Buy
2,806
+1,051
+60% +$534K 0.5% 58
2022
Q3
$797K Buy
1,755
+37
+2% +$17.7K 0.28% 101
2022
Q2
$829K Sell
1,718
-314
-15% -$155K 0.28% 99
2022
Q1
$998K Sell
2,032
-185
-8% -$84.6K 0.3% 85
2021
Q4
$1.03M Sell
2,217
-399
-15% -$168K 0.26% 99
2021
Q3
$975K Buy
2,616
+175
+7% +$66.5K 0.24% 115
2021
Q2
$932K Sell
2,441
-299
-11% -$114K 0.21% 126
2021
Q1
$984K Sell
2,740
-399
-13% -$128K 0.27% 117
2020
Q4
$1.01M Buy
3,139
+575
+22% +$176K 0.3% 102
2020
Q3
$689K Buy
2,564
+1,663
+185% +$447K 0.26% 112
2020
Q2
$237K Sell
901
-356
-28% -$95K 0.09% 192
2020
Q1
$285K Buy
+1,257
New +$343K 0.14% 167

Other funds holding ELV

Intellectus Partners's ELV Position: Q2 2026 in Review

Intellectus Partners held its Elevance Health (ELV) position steady in Q2 2026 at 2,301 shares worth $890K. The position accounts for 0.15% of the portfolio, ranked #152.

Intellectus Partners first reported a position in ELV in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.37M in Q1 2024. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Intellectus Partners held 2,301 shares of Elevance Health worth $890K as of Q2 2026.
  • Intellectus Partners left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.15% of Intellectus Partners's portfolio in Q2 2026, its #152 holding.
  • Intellectus Partners first reported a position in Elevance Health in Q1 2020 and has held it in 26 quarters since.
  • Intellectus Partners's Elevance Health position peaked at $2.37M in Q1 2024.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.